Naoto Hirano, MD, PhD

Princess Margaret Cancer Centre

Disclosure information not submitted.

Presentation(s):

• Welcome

  Thursday, April 16, 2026
  12:45 PM - 12:50 PM US ET

• Peptide-Centric HLA Class II Immunotherapy: Overcoming HLA Restriction for Broad Cancer Targeting

  Thursday, April 16, 2026
  12:50 PM - 1:05 PM US ET